Search

Displaying results 9751 - 9760 of 10000 in total
  1. Drug

    Bevurogant

    go.drugbank.com/drugs/DB21507
    Experimental

    The usage of the INN stem '-rogant' in the name indicates that Bevurogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.

  2. Drug

    Izumerogant

    go.drugbank.com/drugs/DB21604
    Experimental

    The usage of the INN stem '-rogant' in the name indicates that Izumerogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.

  3. Drug

    Chiauranib

    go.drugbank.com/drugs/DB16124
    Investigational

    Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).

  4. Drug

    KAHR-102

    go.drugbank.com/drugs/DB17427
    Investigational

    KAHR-102 is a dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL).

  5. Drug

    Thymocartin

    go.drugbank.com/drugs/DB20928
    Experimental

    Thymocartin is a small molecule drug. Thymocartin has a monoisotopic molecular weight of 516.3 Da.

    Categories: Amino Acids, Peptides, and Proteins, Hormones, Hormone Substitutes, and Hormone Antagonists
  6. Drug

    (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

    go.drugbank.com/drugs/DB08553
    Experimental

    This compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.

  7. Drug

    Cadralazine

    go.drugbank.com/drugs/DB13452
    Experimental

    Categories: Arteriolar Smooth Muscle, Agents Acting On
  8. Drug

    Gemopatrilat

    go.drugbank.com/drugs/DB20954
    Experimental

    Gemopatrilat is a small molecule drug. Gemopatrilat has a monoisotopic molecular weight of 378.16 Da.

    Categories: Agents Acting on the Renin-Angiotensin System
  9. Drug

    Vocimagene amiretrorepvec

    go.drugbank.com/drugs/DB15331
    Investigational

    Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).

    Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins
  10. Drug

    Dimericine

    go.drugbank.com/drugs/DB17833
    Investigational

    Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins